Breaking News

You are here » Indian-Commodity  :  Investment  :  Graphite India inks agreement for investment in General Graphene

03-Sep2018

Graphite India inks agreement for investment in General Graphene

Graphite India through its wholly owned subsidiary in Netherlands, Graphite International BV has signed a definitive agreement for investment upto $18.6 million in cash in General Graphene Corporation. This investment would constitute approximately 46% stake in General Graphene and is aligned to the company's core business segment of Carbon and Graphite.

General Graphene has developed a breakthrough proprietary technology which would allow them to produce large area, low cost graphene sheets industrial volumes for commercial applications. The investment will be made in multiple tranches over 2 to 3 years, based on the achievement of agreed milestones in the process of commercial production of grapheme sheets.

Graphite India is the pioneer in India for manufacture of Graphite Electrodes as well as Carbon and Graphite Speciality products.


Related News

View all news

Northern Multi Manager acquires 16.94 lakh shares of Mindtree

Northern Multi Manager Emerging Markets Equity Fund has bought 16.94 lakh equity shares of Mindtree for Rs 840.01 per share on the BSE on November 16, 2018. However, Copthall Mauritius Investment has offloaded......

Spice Mobility's arm to make investment in Fast Track IT Solutions

Spice Mobility's step down subsidiary -- S Global Services, Singapore, (SGIC) has decided to invest BDT233,333 in Fast Track IT Solutions, a private company limited by shares incorporated under the laws......

Alka Securities gets nod to initiate investment in consultancy partnership

Alka Securities has received an approval to initiate investment in a consultancy partnership. The Board of Directors of the company at their meeting held on November 14, 2018, approved the same and has......

Top News

View all news

Siemens reports 55% fall in Q4 net profit

Siemens has reported results for fourth quarter ended September 30, 2018.The company has reported 55.24% fall in its net profit at Rs 279.20 crore for the quarter under review as compared to Rs 623.80......

USFDA completes audit of Dr. Reddy's Andhra Pradesh facility

The US Food and Drug Administration (USFDA) has completed the audit of Dr. Reddy's Laboratories' Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh on November 16, 2018 with zero observations.Dr.......

PNB Gilts reports 71% rise in Q2 net profit

PNB Gilts has reported results for second quarter ended September 30, 2018.The company has reported 71.36% rise in its net profit at Rs 11.07 crore for the quarter under review as compared to Rs 6.46 crore......